Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 1,600 shares. Based on an average daily volume of 20,345 shares, the days-to-cover ratio is currently 0.1 days.
Fortress Biotech Stock Up 1.7%
NASDAQ FBIOP traded up $0.27 on Thursday, hitting $16.75. 11,710 shares of the stock were exchanged, compared to its average volume of 19,612. The stock has a fifty day moving average price of $18.10 and a two-hundred day moving average price of $17.53. Fortress Biotech has a 52-week low of $6.27 and a 52-week high of $21.43.
About Fortress Biotech
Fortress Biotech, Inc is a biopharmaceutical company focused on developing and commercializing medicines for serious diseases with significant unmet medical needs. The company uses a subsidiary-based business model in which specialized biotechnology companies advance therapies in areas including oncology, dermatology, rare diseases, infectious diseases and neurology.
Fortress and its subsidiaries develop products across multiple stages, from early research and clinical development to regulatory approval and commercialization.
See Also
- Five stocks we like better than Fortress Biotech
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
